|
| Press Releases |
|
 |
|
| Friday, February 6, 2026 |
|
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets |
| On February 6, 2026, according to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC) has acquired an initial stake in Ascletis Pharma (1672. HK). more info >> |
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share |
| on 5 February, GIC Private Limited made its first equity investment in Ascletis Pharma (01672) by acquiring 64,128,000shares at a price of HKD12.18per share more info >> |
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元 |
| 2026年2月6日報道，根據香港聯交所2月6日披露的文件，新加坡政府投資公司（GIC Private Limited）於2月5日首次入股歌禮製藥（01672）。 more info >> |
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元 |
| 2026年2月6日报道，根据香港联交所2月6日披露的文件，新加坡政府投资公司（GIC Private Limited）于2月5日首次入股歌礼制药（01672）。 more info >> |
|
| Thursday, February 5, 2026 |
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share |
| According to the disclosure of interests information released by the Hong Kong Stock Exchange, GIC Private Limited made its equity investment in Ascletis Pharma by acquiring 64,128,000shares at a price of HKD12.18per share, involving a total consideration of approximately HKD781.08million (equivalent to approximately USD100.01 million). more info >> |
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司入股6412.8萬股 涉資約1億美元 |
| 根據香港聯交所披露的文件，新加坡政府投資公司（GIC Private Limited）入股歌禮製藥，以每股均價12.18 港元，買入 64,128,000 股普通股股份，合計涉資約7.81億港元，折合約1億美元。 more info >> |
|
|
歌礼制药-B（01672）获新加坡政府投资公司入股6412.8万股 涉资约1亿美元 |
| 根据香港联交所披露的文件，新加坡政府投资公司（GIC Private Limited）入股歌礼制药，以每股均价12.18 港元，买入 64,128,000 股普通股股份，合计涉资约7.81亿港元，折合约1亿美元。 more info >> |
|
| Wednesday, August 1, 2018 |
|
|
Ascletis Successfully Listed on the Main Board of HKEX |
| Recently, following the official implementation of the revised listing rules by the Hong Kong Stock Exchange (HKEX), the Hong Kong capital market has been opened up further, welcoming listing applications from several biotechnology companies. more info >> |
|
|
中國首個原研全口服丙肝治愈方案上市申請獲受理 |
| 歌禮今日宣布，公司向國家藥品監督管理局遞交的中國首個原研全口服丙肝治愈方案上市申請已獲受理。 more info >> |
|
|
中国首个原研全口服丙肝治愈方案上市申请获受理 |
| 歌礼今日宣布，公司向国家药品监督管理局递交的中国首个原研全口服丙肝治愈方案上市申请已获受理。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
華商能源戰略轉型成效明顯 業績規模展現公司韌性
Mar 28, 2026 17:44 HKT/SGT
|
|
|
CALB (3931.HK) Announces 2025 Results with Record Revenue of RMB 44,400.07 Million, Up 60% YoY
Mar 28, 2026 17:36: JST
|
|
|
华商能源战略转型成效明显 业绩规模展现公司韧性
Mar 28, 2026 17:29 HKT/SGT
|
|
|
停車場變機器人母港：首程控股(0697.HK)用資產管理邏輯重塑靜態交通基礎設施
Mar 28, 2026 17:14 HKT/SGT
|
|
|
From Parking Lots to Robot Hubs: Shoucheng Holdings (0697.HK) Redefines Static Transport Infrastructure Through Asset Management Logic
Mar 28, 2026 17:01 HKT/SGT
|
|
|
中創新航（3931.HK）公佈2025年全年業績
Mar 28, 2026 16:52 HKT/SGT
|
|
|
中创新航（3931.HK）公布2025年全年业绩
Mar 28, 2026 16:45 HKT/SGT
|
|
|
CALB (3931.HK) Announces 2025 Results with Record Revenue of RMB 44,400.07 Million, Up 60% YoY
Mar 28, 2026 16:36 HKT/SGT
|
|
|
Ausnutria 2025 Annual Results: Revenue Powered by International Business and Family Nutrition, Lean Management Underpins Operational Resilience
Mar 28, 2026 16:15 HKT/SGT
|
|
|
澳優2025年業績公告：營業收入韌性增長 全家營養、國際業務雙布局協同發力 佳貝艾特海外營收勁漲50.7%
Mar 28, 2026 16:08 HKT/SGT
|
|
|
澳优2025年业绩公告：营业收入韧性增长 全家营养、国际业务双布局协同发力 佳贝艾特海外营收劲涨50.7%
Mar 28, 2026 16:00 HKT/SGT
|
|
|
Gench Education Announces 2025 Annual Results
Mar 28, 2026 15:43 HKT/SGT
|
|
|
建橋教育公佈2025年全年業績
Mar 28, 2026 15:17 HKT/SGT
|
|
|
Thailand Cat Lovers Fair 2026 Returns with Immersive "MEOW LAND" Experience
Mar 28, 2026 10:27: JST
|
|
|
Vantage Goldfields Corrects Misleading Announcement by Lions Bay Capital Inc. (LBI)
Mar 28, 2026 06:26 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
